Publications found:
33,058
Sort by:
Calming and Sleeping in Kazakhstan
US$ 990.00
... on people, affected sales of calming and sleeping products in 2012. Many Kazakh consumers prefer trying non-prescription calming and sleeping product before visiting the ... step in treatment as these, mostly herbal, remedies... Euromonitor International's Calming and Sleeping in Kazakhstan report offers a comprehensive guide to the size and shape of the ...
April 2013
19 pages
NRT Smoking Cessation Aids in Kazakhstan
US$ 990.00
... effective, since the number of smoking population rises on an annually basis. A number of very strong anti-smoking... Euromonitor International's NRT Smoking Cessation Aids in Kazakhstan report offers a comprehensive guide ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
April 2013
20 pages
Emergency Contraception in Kazakhstan
US$ 990.00
Emergency contraception products in Kazakhstan are Rx, since they might be overused, particularly by younger consumers. Euromonitor International's Emergency Contraception in Kazakhstan report offers a comprehensive guide to the size and ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
April 2013
16 pages
OTC Triptans in Kazakhstan
US$ 990.00
Towards the end of the review period, all triptans remained Rx in Kazakhstan. Euromonitor International's OTC Triptans in Kazakhstan report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving change ...
April 2013
16 pages
Emergency Contraception in Sweden
US$ 990.00
... for Swedish emergency contraception in 2012. This is primarily due to new importers that entered the market and increased competition. Euromonitor International's Emergency Contraception in Sweden report ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
April 2013
23 pages
OTC Triptans in Sweden
US$ 990.00
The most likely customer of OTC triptans products in Sweden suffers from migraines but has not been diagnosed by a medical ... a key driver of sales and value growth in 2012. Euromonitor International's OTC Triptans in Sweden report offers a comprehensive guide to the size and shape of the ...
April 2013
24 pages
ENANTA PHARMA - Debut of a Star- 2nd in the Oral IFN free HCV Drug Race!
US$ 140.00
... acquisition of Pharmasset in 2011 and ABBV through its alliance with Enanta (ENTA) in 2006. Gilead’s Sofosbuvir (PhIII, PMI) in combination with RBV ... our initiation report released on 17th April, 2013 on ENTA titled “Debut of a Star- 2nd in the Oral IFN free HCV Drug Race ...
April 2013
8 pages
Calming and Sleeping in Azerbaijan
US$ 990.00
... of depression on the other side also resulted in growing consumption of calming and sleeping products. Advertisements of these products through television and posters, as well ... working life, continued contributing to the growth. Euromonitor International's Calming and Sleeping in Azerbaijan report offers a comprehensive guide to the size and shape of the ...
April 2013
19 pages
Emergency Contraception in Azerbaijan
US$ 990.00
Still, there is no emergency contraception available in Azerbaijan. All medicines are Rx only Euromonitor International's Emergency Contraception in Azerbaijan report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
April 2013
16 pages
NRT Smoking Cessation Aids in Azerbaijan
US$ 990.00
... stimulus to organise special zones for smokers, to prevent... Euromonitor International's NRT Smoking Cessation Aids in Azerbaijan report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
April 2013
19 pages
OTC Triptans in Azerbaijan
US$ 990.00
... drugs classified as triptans remained Rx in Azerbaijan. Doctors can prescribe triptans to patients suffering from migraines if this diagnosis is approved. Euromonitor International's OTC Triptans in Azerbaijan report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving change ...
April 2013
16 pages
Chinese Pharmaceutical Market 2013-2023
US$ 2,635.00
... , and clinical trials outsourcing Contract manufacturing and other domestic pharmaceutical manufacturing - with division into drug formulations, active pharma ingredients ( ... stay ahead. Discover what potential China holds. Eight main ways Chinese Pharmaceutical Market 2013-2023 helps you In particular then, ...
April 2013
218 pages
Pharma Wholesale and Distribution Market: World Outlook 2013-2023
US$ 2,635.00
... level? Our work shows you individual revenue forecasts for 11 top wholesalers and distributors, including these: McKesson Cardinal Health AmerisourceBergen Alliance ... new report shows you the possibilities. Nine ways Pharma Wholesale and Distribution Market: World Outlook 2013-2023 helps To sum up, our ...
April 2013
203 pages
Emergency Contraception in China
US$ 990.00
... value of emergency contraception continued to grow in 2012, by 7%, as more women turned to these products to avoid unwanted pregnancies. The one-child policy in China, which restricts ... if one of the parents is themselves an only child, most families in China... Euromonitor International's Emergency Contraception in China report offers a comprehensive guide to the size and shape ...
April 2013
36 pages
China Vitamin Industry Report, 2012-2015
US$ 1,800.00
... impact of the economic downturn in Europe and the United States, China’s future vitamin market will face grim situation, especially exports even ... also with average export prices lifted to varying degrees . China Vitamin Industry Report, 2012-2015 of ResearchInChina mainly covers the followings: International ...
April 2013
73 pages
Competitor Analysis: Antibody-Drug Conjugates (ADC)
US$ 785.00
Product description The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated via a linker with a drug payload for treatment of cancer as of April 2013. Purchase of the ...
April 2013
104 pages
Competitor Analysis: Insulin
US$ 590.00
Product description The Competitive Intelligence Report Insulin as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant insulin and in...
April 2013
89 pages
Competitor Analysis: Interferon
US$ 590.00
Product description The Competitive Intelligence Report Interferon as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant and natural...
April 2013
89 pages
Canadian Market for Hyaluronic Acid Viscosupplementation
US$ 3,995.00
In 2012, the Canadian hyaluronic acid viscosupplementation market was valued at $13 million, an increase over the previous year. The market includes two ... overall market and will continue to do so over the forecast period. Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Canada. ...
March 2013
50 pages
Ophthalmic Drugs: World Market Prospects 2013-2023
US$ 2,635.00
... Generic competition. Also, we discuss these aspects of the field: Development of new drug delivery methods and formulations Sustained-release ocular Implants New ... possibilities, helping you stay ahead. Eight ways Ophthalmic Drugs: World Market Prospects 2013-2023 helps To sum up, our investigation gives ...
March 2013
222 pages
Calming and Sleeping in Uruguay
US$ 990.00
... with a prescription is clearly determined. Psychotropic drugs used for calming and sleeping can only be acquired with special registered and numbered prescriptions ... de Salud Pública, especially for each physician who... Euromonitor International's Calming and Sleeping in Uruguay report offers a comprehensive guide to the size and shape ...
March 2013
18 pages
Emergency Contraception in Uruguay
US$ 990.00
... é Vázquez, who had vetoed the articles relating... Euromonitor International's Emergency Contraception in Uruguay report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
March 2013
20 pages
NRT Smoking Cessation Aids in Uruguay
US$ 990.00
... , and 2012. The government also sponsored smoking cessation clinics, with low-cost... Euromonitor International's NRT Smoking Cessation Aids in Uruguay report offers a comprehensive guide to the size ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
March 2013
19 pages
Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2013-2023
US$ 2,635.00
... There you discover activities of these prominent organisations: Catalent Hospira One2One Vetter Pharma. There you also assess the competitive outlook for leading CMOs ... that market and its leading companies. Seven ways Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2013-2023 helps you ...
March 2013
170 pages
Antibacterial Drugs: World Market Prospects 2013-2023
US$ 2,635.00
... also analyses these participants, and discusses other companies in the market: Cubist Pharmaceuticals AstraZeneca Taisho Toyama Pharmaceutical AbbVie Daiichi Sankyo ... possibilities, helping you stay ahead. Ten ways Antibacterial Drugs: World Market Prospects 2013-2023 helps you In particular then, our ...
March 2013
235 pages
Singapore Pharmaceutical Industry Report - H2, 2012
US$ 475.00
... of value addition. Also, the report encompasses the profile of leading players in the pharmaceutical industry as well as their respective financial highlights and SWOT analysis. Among the leading pharmaceutical players in Singapore are Luye Pharma Group Limited, Star Pharmaceuticals Limited ...
March 2013
30 pages
Global Tablet Market Report 2013-2018: Will Apple Remain the Incumbent?
US$ 2,400.00
... topple Apple's dominance. Visiongain has determined that the value of the global tablet market in 2013 will reach $53.6bn. Key amongst Apple's new rivals ... highlighting strategic business opportunities. Why you should buy the Global Tablet Market Report 2013-2018: Will Apple Remain the Incumbent? 138 pages ...
March 2013
138 pages
Immunochemistry Reagents, Analysers And Test Kits: World Market 2013-2023
US$ 2,635.00
... to 2023. It explains trends, opportunities and prospects for immunochemistry reagents, analysers and test kits. There's rising demand for those products. ... outlook in key segments of the market Strengths and weaknesses of the immunochemistry market Also, you find coverage of these aspects: Medical device ...
March 2013
160 pages
Emergency Contraception in Australia
US$ 990.00
Emergency contraception is available in Australia. The product is Schedule 3, which means it can only be sold from behind the counter, involving interaction with a pharmacist. The emergency contraceptive pill has been available in Australia since 2004, thus the category is still maturing. Euromonitor International's Emergency Contraception in Australia report offers a comprehensive ...
March 2013
22 pages
India Pharmaceuticals Industry Report - H2, 2013
US$ 475.00
... & Healthcare provides an overview of the industry in Asia Pacific and India. India’s pharmaceutical industry grew by 9.7% year-on-year in 2009-2010, largely due ... in 2009-2010, largely due to robust growth in the domestic market. India’s healthcare industry is expected to grow 14% per year to reach USD 280 ...
March 2013
29 pages
Dermatological Drugs: World Market Prospects 2013-2023
US$ 2,635.00
... 2013: Reformulations and combination therapies Generic competition and new drug classes Needs for antibacterial, antiviral and antifungal treatments Patient ... possibilities, helping you stay ahead. Nine ways Dermatological Drugs: World Market Prospects 2013-2023 helps To sum up, our investigation gives ...
March 2013
200 pages
Calming and Sleeping in Croatia
US$ 990.00
Calming and sleeping is still one of the smallest categories in OTC products, with only a 2% share of value sales in 2012. It seems that when it comes to sleeping disorders, Croatians tend to look for stronger medication, for instance Rx products. Euromonitor International's Calming and Sleeping in Croatia report offers a comprehensive ...
March 2013
21 pages
Global Oncology Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis, March 2013
US$ 2,650.00
... in 2018. Lucintel, a leading global management consulting and market research firm, has analyzed the global oncology drugs industry and presents its findings in Global Oncology Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis. The industry comprises firms primarily engaged in the development, manufacture, and marketing of oncology drugs. Lucintels ...
March 2013
The Top 10 Pharma Companies in 2017
US$ 595.00
... extensive analysis from experts in many fields to predict the top 10 Pharma companies in 2017. To stay ahead of your competition, you need to have the ... fingertips. Download this powerful report today. Each of the top 10 pharma companies for 2017 has its own report, providing an overall sales ... for the ten pharma companies that are expected to lead the market in 2017 Analyst consensus sales forecasts for each company’s top five ...
February 2013
223 pages
The World Market for Implantable and Needle-Free Drug Delivery Systems
US$ 2,995.00
This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and ... Drug Delivery Systems by Pharmaceutical and Drug Delivery Component Selected Suppliers of Implantable/Injectable Drug Delivery Technology Cost per Million Injections by Injector ...
February 2013
120 pages
Research Report on China’s Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017
US$ 1,800.00
Benign prostatic hyperplasia (BPH) is a common disease among middle-aged and elderly men, with an increasing morbidity as the rise in ages. Its invasion ... patent drug manufacturers. Meanwhile, it is also a huge market. Therefore, the prospect of China’s anti-PH drug market is very bright. The annual growth rate ...
February 2013
40 pages
Antithrombotic Drugs: World Market 2013-2023
US$ 2,635.00
... What prospects for leading countries? Developments worldwide will influence the market, especially rising demand in emerging countries - e.g. Brazil and China. Our ... possibilities, helping you stay ahead. Nine ways Antithrombotic Drugs: World Market 2013-2023 helps To sum up, our investigation gives you ...
February 2013
119 pages
Pharma and the mHealth Revolution - Engaging with Mobile-Enabled Physicians and HCPs
US$ 595.00
... and mHealth developers themselves. Whether your company is looking to expand into mHealth apps or seeking sound advice on a way forward, Pharma and the mHealth Revolution - engaging ... from pharma in developing mHealth apps for healthcare providers Detailed insight into five major pharma mHealth projects Methodologies for determining the platforms on which mHealth ...
January 2013
83 pages
IVD Procedure Volume and Pricing Analysis
US$ 3,995.00
... categories., Global procedure volume estimates are provided for the historic 2012 period and forecasts are provided through 2017. Price estimates are ... growth through the foreseeable future. Which company is performing what share of IVD procedures? This unique business planning tool answers this question, ...
January 2013
210 pages
VERTEX PHARMA - Faltering Pipeline and Sales
US$ 140.00
Vertex Pharma (VRTX) 4Q12/FY12 earnings and FY13 guidance (total revenue: ... is banking on success of its Cystic Fibrosis (CF) drugs in the pipeline for resurrection. VRTX endeavors could be too late in competing from ... read our report released on 31st January, 2013 on Vertex titled “Faltering Pipeline and Sales”
January 2013
4 pages
Research Report on China’s Anti-Alzheimer’s Disease (AD) Drug Market, 2013-2017
US$ 2,800.00
... the end of 2011, people aged 60 and above reached 185 million in China, accounting for 13.7% of the population, with an increase of 0.47 percentage point compared ... market development also accelerates. Although the overall market size of China's anti-AD drug market is relatively small, the growth rate is always ...
January 2013
40 pages
Pharma Clinical Trial Services: World Market 2013-2023
US$ 2,400.00
... will increase its revenues from 2013 to 2023, achieving strong growth. Clinical research organisations (CROs) and their clients will benefit. The ... you the technological and commercial possibilities. Eight ways Pharma Clinical Trial Services: World Market 2013-2023 helps To sum up, our investigation ...
January 2013
189 pages
Food Safety Diagnostics, The World Market
US$ 2,500.00
... unprecedented in an age of mass media, consumer alert systems and industrialized food production that together have led to high publicized outbreaks and food ... to pathogenic microbes Unlike other studies on the market, Food Safety Diagnostics, The World Market does not limit analysis to pathogens alone. ...
January 2013
140 pages
Vaccine Manufacturing Technology and Services: World Market 2013-2023
US$ 2,400.00
... revenues to 2023. It explains trends, opportunities and prospects for those technologies.а Our study lets you assess sales data at overall world ... and commercial possibilities. Eight ways Vaccine Manufacturing Technology and Services: World Market 2013-2023 helps In particular, then, our investigation ...
January 2013
194 pages
